• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Eurazeo injects €134m into Les Petits Chaperons Rouges

  • Greg Gille
  • Greg Gille
  • @unquotenews
  • 30 March 2016
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

French listed investor Eurazeo has invested €134m in exchange for a minority stake in nursery operator Les Petits Chaperons Rouges (LPCR).

The transaction was structured as a buyout, allowing previous backer Five Arrows to exit the business. The Rothschild investment arm had supported the owner buyout of the company in 2010, according to unquote" data.

Eurazeo provided a total of €134m in equity and convertible bonds. It secured a 41% stake while co-investor BPI France will hold onto 8% of the shares. The company's co-founder and chair, Jean-Emmanuel Rodocanachi, will own a 51% stake.

Les Petits Chaperons Rouges

  • DEAL:

    OBO

  • VALUE:

    n/d (<€200m est)

  • LOCATION:

    Clichy

  • SECTOR:

    Specialised consumer services

  • FOUNDED:

    2000

  • TURNOVER:

    €144m

  • STAFF:

    3,200

  • VENDOR:

    Five Arrows

Eurazeo told unquote" it had been following the nursery sector for a number of years with a view to invest in that space. It initiated discussion with Rodocanachi in Q3 last year, as the co-founder was looking for a backer for the next step of LPCR's development.

This marks the second sizeable transaction in as many days for Eurazeo: on 29 March, the listed investor announced it had secured a majority stake in the secondary buyout of French bedding business MK Direct via its small- and mid-cap arm, Eurazeo PME. The firm invested €49m in a deal valuing the business at €102m.

Company
Founded in 2000, LPCR is a private operator of nurseries across France with a network of 850 facilities, 250 of which it directly operates. Its 900 clients include companies, public authorities and local communities. With 3,200 employees, the group reported average annual revenue growth of 21% between 2010 and 2015, with turnover increasing from €56m to €144m in that time frame.

People
Eurazeo – Vivianne Akriche (director); Amandine Ayrem (associate); Grégoire Leleu (analyst).
LPCR – Jean-Emmanuel Rodocanachi (co-founder, chair).

Advisers
Equity - Lazard, Charles Andrez (M&A); Skadden, Olivier Diaz, Céline Gainet, Thomas Perrot, Guillaume Roche (legal); PwC Transaction Services, Guillaume Lorain, Sophie Gerbaud, Clémence Chauvin (financial due diligence); PwC Société d'Avocats, Fabien Radisic, Aurélie Cluzel-d'Andlau et Yannick Olivier (legal, tax).

 

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • France
  • Exits
  • Consumer
  • France
  • Eurazeo
  • Rothschild

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013